Lvw Advisors, LLC Hutchmed (China) LTD Transaction History

Lvw Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$15.52 - $35.65 $109,555 - $251,653	-7,059 Closed	0 $0
Q4 2021 Jan 26, 2022	SELL	$28.89 - $35.33 $18,402 - $22,505	-637 Reduced 8.28%	7,059 $248,000
Q3 2021 Nov 02, 2021	SELL	$35.66 - $42.94 $249 - $300	-7 Reduced 0.09%	7,696 $282,000
Q2 2021 Jul 15, 2021	BUY	$23.7 - $39.27 $616 - $1,021	26 Added 0.34%	7,703 $302,000
Q1 2021 Apr 19, 2021	BUY	$27.01 - $36.8 $31,061 - $42,320	1,150 Added 17.62%	7,677 $217,000
Q4 2020 Feb 04, 2021	SELL	$27.51 - $34.36 $302 - $377	-11 Reduced 0.17%	6,527 $209,000
Q3 2020 Oct 29, 2020	BUY	$25.8 - $34.61 $168,680 - $226,280	6,538 New	6,538 $211,000

6.88M

6.2K

1.1K

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $2.35B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lvw Advisors, LLC with notifications on news.